News

EVALI (E-cigarette or Vaping product use-Associated Lung Injury)

Feb 1, 2020, 00:00 AM by MSDC staff
The latest information on E-cigarette or Vaping product use-Associated Lung Injury.
Numbers from the CDC
2,711: # of cases of hospitalized e-cigarette, or vaping, product use associated lung injury (EVALI)
60: # of confirmed deaths from vaping-related lung injury have been confirmed in 25 states and the District of Columbia
 
The CDC figures above are as of January 21, 2020.

Note: As of December 4, 2019, CDC figures only report hospitalized EVALI cases and EVALI deaths regardless of hospitalization status. CDC has removed nonhospitalized cases from previously reported cases counts. For more, see the CDC's "Outbreak of Lung Injury Associated with E-cigarette, or Vaping, Products"

Note as of November 21: CDC states it "has identified vitamin E acetate as a chemical of concern among people with EVALI. ... CDC laboratory testing of bronchoalveolar lavage fluid samples (fluid samples collected from the lungs) from 29 patients with EVALI submitted to CDC from 10 states found vitamin E acetate in all of the samples. Vitamin E acetate is used as an additive, most notably as a thickening agent in THC-containing e-cigarette, or vaping, products." See CDC's Key Facts about Vitamin E Acetate

How to Report Vaping Lung Disease
In September, the DC Department of Health issued astatement advising residents to stop using e-cigarettes. Healthcare providers are encouraged to promptly report any suspected cases of illness related to e-cigarette use you have seen since July to the District of Columbia Department of Health using the Notifiable Disease and Condition Case Report Form.
 
For information on reporting cases in Maryland, see this fact sheet from Montgomery County Medial Society.

Resources
 
Load more comments
avatar
New code